A single-center experience of EMA/CO chemotherapy for high -risk gestational trophoblastic neoplasia: Induction low-dose cisplatin and etoposide chemotherapy improves outcome.

被引：0
|
作者：
Alifrangis, C.
Agarwal, R.
Short, D.
Savage, P.
Seckl, M.
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med Oncol, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Res Ctr, London, England
[3] Charing Cross Hosp, Trophoblast Dis Serv, London, England
[4] Charing Cross Hosp, Trophoblast Dis Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
    Alifrangis, Constantine
    Agarwal, Roshan
    Short, Delia
    Fisher, Rosemary A.
    Sebire, Neil J.
    Harvey, Richard
    Savage, Philip M.
    Seckl, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 280 - 286
  • [2] Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia
    Lybol, C.
    Thomas, C. M. G.
    Blanken, E. A.
    Sweep, F. C. G. J.
    Verheijen, R. H.
    Westermann, A. M.
    Boere, I. A.
    Reyners, A. K. L.
    Massuger, L. F. A. G.
    van Hoesel, R. Q. G. C. M.
    Ottevanger, P. B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) : 860 - 867
  • [3] Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
    Turan, T
    Karacay, O
    Tulunay, G
    Boran, N
    Koc, S
    Bozok, S
    Kose, MF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1432 - 1438
  • [4] Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy
    Lurain, John R.
    Singh, Diljeet K.
    Schink, Julian C.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2006, 51 (10) : 767 - 772
  • [5] EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients
    Lu, W. -G.
    Ye, F.
    Shen, Y. -M.
    Fu, Y. -F.
    Chen, H. -Z.
    Wan, X. -Y.
    Xie, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 357 - 362
  • [6] Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors
    Newlands, ES
    Mulholland, PJ
    Holden, L
    Seckl, MJ
    Rustin, GJS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 854 - 859
  • [7] The use of EMA-CO in high-risk gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience
    Ghosh, S.
    Baron, E.
    Nevadunsky, N.
    Goldstein, D.
    Horowitz, N.
    Berkowitz, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S91 - S92
  • [8] High-Risk Metastatic Gestational Trophoblastic Neoplasia Primary Management with EMA-CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Chemotherapy
    Cagayan, Ma. Stephanie Fay S.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (5-6) : 231 - 236
  • [9] Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
    Seresht, Leila Mousavi
    Farazestanian, Marjaneh
    Yousefi, Zohreh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 108 - 111
  • [10] WEEKLY EMA CO CHEMOTHERAPY FOR HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS (GTTS)
    NEWLANDS, ES
    RUSTIN, GJS
    BAGSHAWE, KD
    BEGENT, RHJ
    HOLDEN, L
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 202 - 202
12345